Autolus Therapeutics
AUTL | NASDAQ
$1.94
$0 (0.00%)
At close: Sep 21, 2026, 4:00 PM ET
$1.97
+$0.03 (+1.55%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 75.56M | 10.12M | 1.7M | 6.19M | 1.51M | 1.72M |
Cost of Revenue | 96.59M | 141.02M | n/a | n/a | n/a | 134.89M |
Gross Profit | -21.03M | -130.9M | 1.7M | 6.19M | 1.51M | -133.17M |
Operating Income | -281.44M | -241.43M | -179.7M | -142.89M | -140.37M | -303.13M |
Interest Income | 19.02M | 32.36M | 13.51M | 1.71M | 262K | 536K |
Pretax Income | -296.85M | -219.13M | -208.4M | -148.57M | -142.04M | -166.26M |
Net Income | -288.2M | -220.66M | -208.38M | -148.84M | -142.1M | -142.09M |
Selling & General & Admin | 131.82M | n/a | 46.75M | 31.9M | 31.87M | 34.97M |
Research & Development | 128.59M | 158.14M | 130.48M | 117.35M | 110.84M | 134.99M |
Other Expenses | n/a | -47.61M | 4.17M | -166K | -823K | n/a |
Operating Expenses | 260.41M | 110.53M | 181.4M | 149.09M | 141.88M | 169.96M |
Interest Expense | 36.76M | 9.29M | 45.07M | 8.91M | 1.11M | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 357M | 251.55M | 181.4M | 149.09M | 141.88M | 304.85M |
Income Tax Expense | -8.65M | 1.53M | -19K | 272K | 58K | -24.16M |
Shares Outstanding (Basic) | 266.14M | 255.16M | 173.94M | 94.99M | 72.08M | 51.56M |
Shares Outstanding (Diluted) | 266.14M | 255.16M | 173.94M | 94.99M | 72.08M | 51.56M |
EPS (Basic) | -1.08 | -0.87 | -1.20 | -1.57 | -1.97 | -2.76 |
EPS (Diluted) | -1.08 | -0.87 | -1.20 | -1.57 | -1.97 | -2.76 |
EBITDA | -250.26M | -233.07M | -156.77M | -132.24M | -132.48M | -162.58M |
EBIT | -260.09M | -240.79M | -163.34M | -139.66M | -140.93M | -168.15M |
Depreciation & Amortization | 9.84M | 7.72M | 6.57M | 7.42M | 8.46M | 5.57M |
Add to Watchlist
Select watchlists to add or remove AUTL